IMS Health and Quintiles Transnational, pharmaceutical consulting companies has completed a merger. “This combination addresses life-science companies’ most pressing needs: to transform the clinical development of innovative medicines, demonstrate the value of these medicines in the real world, and drive commercial success. We are bringing together two best-in-class leaders. I’m confident that together we will make our clients even more successful.” Tom Pike, Quintiles Chief Executive Officer.